Funding Rounds
Minoryx Therapeutics

Minoryx Therapeutics Series C (2022, $54M)

Minoryx Therapeutics

Drugs discovery platform for orphan diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $54.74M